Moderna on Wednesday released interim results indicating that its mRNA-1273 COVID vaccine produced “robust” neutralizing antibody titers in children aged 6 months to 6 years — levels similar to those seen in adults. Vaccine efficacy against infection was 43.7% in children aged 6 months to 2 years and 37.5% among […]